Gene expression profiling to predict response to neoadjuvant docetaxel and capecitabine for breast cancer

被引：0
|
作者：
Korde, L.
Zujewski, J.
McShane, L.
Lukes, L.
Lebowitz, P.
Swain, S.
Finney, R.
Hunter, K.
机构：
[1] Natl Canc Inst, Bethesda, MD USA
[2] NCI, Med Oncol Branch, Ctr Canc Res, Bethesda, MD 20892 USA
来源：
BREAST CANCER RESEARCH AND TREATMENT | 2007年 / 103卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：119 / 119
页数：1
相关论文
共 50 条
  • [21] Gene expression and pathologic response to neoadjuvant chemotherapy in breast cancer
    Kolacinska, Agnieszka
    Fendler, Wojciech
    Szemraj, Janusz
    Szymanska, Bozena
    Borowska-Garganisz, Ewa
    Nowik, Magdalena
    Chalubinska, Justyna
    Kubiak, Robert
    Pawlowska, Zofia
    Blasinska-Morawiec, Maria
    Potemski, Piotr
    Jeziorski, Arkadiusz
    Morawiec, Zbigniew
    MOLECULAR BIOLOGY REPORTS, 2012, 39 (07) : 7435 - 7441
  • [22] Potential gene expression meta-signatures predict neoadjuvant chemotherapy response in invasive breast cancer
    Guevara-Nieto, Hedda Michelle
    Parra-Medina, Rafael S.
    Zabaleta, Jovanny
    Lopez-Kleine, Liliana
    Combita, Alba L.
    CANCER RESEARCH, 2024, 84 (06)
  • [23] Gene expression profiling to predict the risk of locoregional recurrence in breast cancer
    Drukker, C. A.
    Nijenhuis, M. V.
    Elias, S. G.
    Wesseling, J.
    Russell, N. S.
    de Snoo, F.
    van't Veer, L. J.
    Beitsch, P. D.
    Rutgers, E. J. T.
    CANCER RESEARCH, 2012, 72
  • [24] Semi-quantitative gene expression profiling for therapy prediction in a breast cancer neoadjuvant therapy study applying docetaxel/epirubicin/cyclophosphamide
    Vogt, U.
    Kemming, D.
    Brandt, B.
    Bosse, U.
    Bonk, U.
    v d Assen, A.
    Muhs, H. J.
    Schlotter, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [25] A novel gene expression signature score to predict response to neoadjuvant therapy, distant metastasis, and survival in breast cancer
    Oshi, Masanori
    Katsuta, Eriko
    Takabe, Kazuaki
    CANCER RESEARCH, 2020, 80 (04)
  • [26] Neoadjuvant chemotherapy in breast cancer: Significantly enhanced response with docetaxel
    Smith, IC
    Heys, SD
    Hutckeon, AW
    Miller, ID
    Payne, S
    Gilbert, FJ
    Ah-See, AK
    Eremin, O
    Walker, LG
    Sarkar, TK
    Eggleton, SP
    Ogston, KN
    JOURNAL OF CLINICAL ONCOLOGY, 2002, 20 (06) : 1456 - 1466
  • [27] Changes in gene expression associated with response to neoadjuvant chemotherapy in breast cancer
    Hannemann, J
    Oosterkamp, HM
    Bosch, CAJ
    Velds, A
    Wessels, LFA
    Loo, C
    Rutgers, EJ
    Rodenhuis, S
    van de Vijver, MJ
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (15) : 3331 - 3342
  • [28] Phase II study of docetaxel, capecitabine, and cisplatin as neoadjuvant chemotherapy for locally advanced breast cancer
    Lu, Yen-Shen
    Chen, Dar-Ren
    Tseng, Ling-Min
    Yeh, Dah-Cherng
    Chen, Shou-Tung
    Hsieh, Chia-Ming
    Wang, Hwei-Chung
    Yeh, Hsien-Tang
    Kuo, Sung-Hsin
    Huang, Chiun-Sheng
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1257 - 1263
  • [29] Gene expression profiling of breast cancer
    Cheang, Maggie C. U.
    van de Rijn, Matt
    Nielsen, Torsten O.
    ANNUAL REVIEW OF PATHOLOGY-MECHANISMS OF DISEASE, 2008, 3 : 67 - 97
  • [30] Gene expression profiling of breast cancer
    Pusztai, Lajos
    BREAST CANCER RESEARCH, 2009, 11
12345